Aβ ‐induced excessive mitochondrial fission drives type H blood vessels injury to aggravate bone loss in APP/PS1 mice with Alzheimer's diseases

Weidong Zhang,Fan Ding,Xing Rong,Qinghua Ren,Tomoka Hasegawa,Hongrui Liu,Minqi Li
DOI: https://doi.org/10.1111/acel.14374
IF: 11.005
2024-10-17
Aging Cell
Abstract:Peripheral circulatory Aβ aggravates the apoptosis of type H ECs, leading to impaired vascularized osteogenesis in AD mice. Further mechanism exploration found Aβ promotes the transfer of Drp1 from the cytosol to the mitochondria by activating GSK‐3β to phosphorylate Drp1 at ser616, leading to excessive mitochondrial fission. Abundant damaged mitochondria appeared and promoted the apoptosis of Type H ECs, due to Aβ‐induced excessive mitochondrial fission. Alzheimer's diseases (AD) patients suffer from more serious bone loss than cognitively normal subjects at the same age. Type H blood vessels were tightly associated with bone homeostasis. However, few studies have concentrated on bone vascular alteration and its role in AD‐related bone loss. In this study, APP/PS1 mice (4‐ and 8‐month‐old) and age‐matched wild‐type mice were used to assess the bone vascular alteration and its role in AD‐related bone loss. Transmission electron microscopy, immunofluorescence staining and iGPS 1.0 software database were utilized to investigate the molecular mechanism. Mitochondrial division inhibitor (Mdivi‐1) and GSK‐3β inhibitor (LiCl) were used to rescue type H blood vessels injury and verify the molecular mechanism. Our results revealed that APP/PS1 mice exhibited more serious bone blood vessels injury and bone loss during ageing. The bone blood vessel injury, especially in type H blood vessels, was accompanied by impaired vascularized osteogenesis in APP/PS1 mice. Further exploration indicated that beta‐amyloid (Aβ) promoted the apoptosis of vascular endothelial cells (ECs) and resulted in type H blood vessels injury. Mechanistically, Aβ‐induced excessive mitochondrial fission was found to be essential for the apoptosis of ECs. GSK‐3β was identified as a key regulatory target of Aβ‐induced excessive mitochondrial fission and bone loss. The findings delineated that Aβ‐induced excessive mitochondrial fission drives type H blood vessels injury, leading to aggravate bone loss in APP/PS1 mice and GSK‐3β inhibitor emerges as a potential therapeutic strategy.
cell biology,geriatrics & gerontology
What problem does this paper attempt to address?